Literature DB >> 20622892

The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models.

Sandra Nell1, Sebastian Suerbaum, Christine Josenhans.   

Abstract

Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, is a major human health problem. The bacteria that live in the gut play an important part in the pathogenesis of IBD. However, owing to the complexity of the gut microbiota, our understanding of the roles of commensal and pathogenic bacteria in establishing a healthy intestinal barrier and in its disruption is evolving only slowly. In recent years, mouse models of intestinal inflammatory disorders based on defined bacterial infections have been used intensively to dissect the roles of individual bacterial species and specific bacterial components in the pathogenesis of IBD. In this Review, we focus on the impact of pathogenic and commensal bacteria on IBD-like pathogenesis in mouse infection models and summarize important recent developments.

Entities:  

Mesh:

Year:  2010        PMID: 20622892     DOI: 10.1038/nrmicro2403

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  157 in total

1.  Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract.

Authors:  Koichi S Kobayashi; Mathias Chamaillard; Yasunori Ogura; Octavian Henegariu; Naohiro Inohara; Gabriel Nuñez; Richard A Flavell
Journal:  Science       Date:  2005-02-04       Impact factor: 47.728

2.  Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis.

Authors:  Uri Gophna; Katrin Sommerfeld; Sharon Gophna; W Ford Doolittle; Sander J O Veldhuyzen van Zanten
Journal:  J Clin Microbiol       Date:  2006-09-20       Impact factor: 5.948

Review 3.  Role of probiotic therapy in IBD.

Authors:  Kim Isaacs; Hans Herfarth
Journal:  Inflamm Bowel Dis       Date:  2008-11       Impact factor: 5.325

4.  Dual infection with Helicobacter bilis and Helicobacter hepaticus in p-glycoprotein-deficient mdr1a-/- mice results in colitis that progresses to dysplasia.

Authors:  Lillian Maggio-Price; Helle Bielefeldt-Ohmann; Piper Treuting; Brian M Iritani; Weiping Zeng; Andrea Nicks; Mark Tsang; Donna Shows; Phil Morrissey; Joanne L Viney
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

5.  Cytolethal distending toxin is essential for Helicobacter hepaticus colonization in outbred Swiss Webster mice.

Authors:  Zhongming Ge; Yan Feng; Mark T Whary; Prashant R Nambiar; Shilu Xu; Vivian Ng; Nancy S Taylor; James G Fox
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

Review 6.  Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis.

Authors:  Martin Feller; Karin Huwiler; Roger Stephan; Ekkehardt Altpeter; Aijing Shang; Hansjakob Furrer; Gaby E Pfyffer; Thomas Jemmi; Andreas Baumgartner; Matthias Egger
Journal:  Lancet Infect Dis       Date:  2007-09       Impact factor: 25.071

7.  Mouse models of intestinal inflammation as tools to understand the pathogenesis of inflammatory bowel disease.

Authors:  Holm H Uhlig; Fiona Powrie
Journal:  Eur J Immunol       Date:  2009-08       Impact factor: 5.532

8.  Lactic acid bacteria inhibit proinflammatory cytokine expression and bacterial glycosaminoglycan degradation activity in dextran sulfate sodium-induced colitic mice.

Authors:  Hye-Sung Lee; Song-Yi Han; Eun-Ah Bae; Chul-Sung Huh; Young-Tae Ahn; Jung-Hee Lee; Dong-Hyun Kim
Journal:  Int Immunopharmacol       Date:  2008-02-05       Impact factor: 4.932

9.  Bacteroides fragilis toxin stimulates intestinal epithelial cell shedding and gamma-secretase-dependent E-cadherin cleavage.

Authors:  Shaoguang Wu; Ki-Jong Rhee; Ming Zhang; Augusto Franco; Cynthia L Sears
Journal:  J Cell Sci       Date:  2007-05-15       Impact factor: 5.285

10.  CD4(+)CD25(+) regulatory lymphocytes require interleukin 10 to interrupt colon carcinogenesis in mice.

Authors:  Susan E Erdman; Varada P Rao; Theofilos Poutahidis; Melanie M Ihrig; Zhongming Ge; Yan Feng; Michal Tomczak; Arlin B Rogers; Bruce H Horwitz; James G Fox
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

View more
  151 in total

Review 1.  Innate immune signaling in defense against intestinal microbes.

Authors:  Melissa A Kinnebrew; Eric G Pamer
Journal:  Immunol Rev       Date:  2012-01       Impact factor: 12.988

2.  Cyclooxygenase-2 silencing for the treatment of colitis: a combined in vivo strategy based on RNA interference and engineered Escherichia coli.

Authors:  Enzo Spisni; Maria C Valerii; Luigia De Fazio; Elena Cavazza; Francesca Borsetti; Annamaria Sgromo; Marco Candela; Manuela Centanni; Fernando Rizello; Antonio Strillacci
Journal:  Mol Ther       Date:  2014-11-13       Impact factor: 11.454

Review 3.  Potential role of chitinases and chitin-binding proteins in host-microbial interactions during the development of intestinal inflammation.

Authors:  H T Tran; N Barnich; E Mizoguchi
Journal:  Histol Histopathol       Date:  2011-11       Impact factor: 2.303

Review 4.  Engineering ecosystems and synthetic ecologies.

Authors:  Michael T Mee; Harris H Wang
Journal:  Mol Biosyst       Date:  2012-10

Review 5.  Insights into inflammatory bowel disease using Toxoplasma gondii as an infectious trigger.

Authors:  Charlotte E Egan; Sara B Cohen; Eric Y Denkers
Journal:  Immunol Cell Biol       Date:  2011-11-08       Impact factor: 5.126

6.  Longitudinal analysis of inflammation and microbiota dynamics in a model of mild chronic dextran sulfate sodium-induced colitis in mice.

Authors:  Luigia De Fazio; Elena Cavazza; Enzo Spisni; Antonio Strillacci; Manuela Centanni; Marco Candela; Chiara Praticò; Massimo Campieri; Chiara Ricci; Maria Chiara Valerii
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

7.  Clostridium difficile infection aggravates colitis in interleukin 10-deficient mice.

Authors:  Mi Na Kim; Seong-Joon Koh; Jung Mogg Kim; Jong Pil Im; Hyun Chae Jung; Joo Sung Kim
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

Review 8.  Microbial metaproteomics for characterizing the range of metabolic functions and activities of human gut microbiota.

Authors:  Weili Xiong; Paul E Abraham; Zhou Li; Chongle Pan; Robert L Hettich
Journal:  Proteomics       Date:  2015-05-28       Impact factor: 3.984

9.  c-FLIP maintains tissue homeostasis by preventing apoptosis and programmed necrosis.

Authors:  Xuehua Piao; Sachiko Komazawa-Sakon; Takashi Nishina; Masato Koike; Jiang-Hu Piao; Hanno Ehlken; Hidetake Kurihara; Mutsuko Hara; Nico Van Rooijen; Günther Schütz; Masaki Ohmuraya; Yasuo Uchiyama; Hideo Yagita; Ko Okumura; You-Wen He; Hiroyasu Nakano
Journal:  Sci Signal       Date:  2012-12-18       Impact factor: 8.192

Review 10.  Visions of Eye Commensals: The Known and the Unknown About How the Microbiome Affects Eye Disease.

Authors:  Anthony J St Leger; Rachel R Caspi
Journal:  Bioessays       Date:  2018-10-05       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.